XML 63 R10.htm IDEA: XBRL DOCUMENT v2.4.1.9
Going Concern
12 Months Ended
Dec. 31, 2014
Going Concern:  
Going Concern

Note 2 – Going Concern

 

The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company has had recurring operating losses and negative cashflows from operations. Those factors, as well as uncertainty in securing additional funds for continued operations, create an uncertainty about the Company’s ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

The Company plans to finance its operations for the next 12 months through Biotech IP licensing fee revenues and private sales of equity and debt securities to accredited investors.